Cell Biology and Signaling
Cell Biology and Signaling
批准号:
7712901
负责人:
RICHARD G PESTELL
金额:
$2.56万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-05 至 2013-05-31
关键词:
AddressApoptosisAreaBasic ScienceCancer BiologyCell ProliferationCell physiologyCellsCellular biologyClinicalDevelopmentDiagnosticExtracellular MatrixFosteringFundingFutureG Protein-Coupled Receptor SignalingGoalsGrantGrowthMalignant - descriptorMalignant NeoplasmsManuscriptsMissionMolecularNeoplasm MetastasisPeer ReviewPersonal SatisfactionProcessProtein Tyrosine KinasePublishingResearchResearch PersonnelRoleSignal PathwaySignal TransductionSignaling MoleculeTextTherapeutic AgentsTissuesTranslatingTranslational ResearchTranslationsUnited States National Institutes of HealthWorkangiogenesiscancer cellcancer therapycell growthcell growth regulationinsightinterestmembermigrationneoplastic cellnovel therapeuticsprograms
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CANCER CELL BIOLOGY AND SIGNALING PROGRAM
The Cancer Cell Biology and Signaling Program is comprised of nineteen investigators from six
departments. The program mission is to elucidate the role of cell signaling in regulating cell growth,
differentiation, and apoptosis. The program focuses on three major areas of research: 1) understanding the
molecular mechanisms involved in the regulation of cell growth and differentiation with an emphasis on the
role of tyrosine kinase and G protein-coupled receptor signaling pathways; 2) elucidating the molecular
mechanisms regulating cell apoptosis; and 3) addressing the role of the extracellular matrix in regulating
cell growth and migration.
An important scientific goal of this program is to integrate fundamental studies on the mechanisms that
regulate cell growth, differentiation, and apoptosis with the translational research efforts at the KCC. This
should result in a better understanding of the biology of cancer and also in the translation of basic research
into novel therapeutic strategies for the treatment of cancer. All program members are NIH funded. They
currently have $2.6 million of NCI support and $9.8 million of total, peer-reviewed support. Program
members published a total of 320 cancer-relevant manuscripts (8% intra-programmatic and 13% interprogrammatic)
during the last grant period.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CCR5 inhibitors to enhance therapeutic response of breast cancer to DNA damaging agents
-
批准号:10057534
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2020
-
负责人:RICHARD G PESTELL
-
依托单位:
Molecular Biology and Genetics Program
-
批准号:8753662
-
项目类别:
-
资助金额:$3.0万
-
财政年份:2014
-
负责人:RICHARD G PESTELL
-
依托单位:
Translational Research in Cancer
-
批准号:8738098
-
项目类别:
-
资助金额:$7.32万
-
财政年份:2013
-
负责人:RICHARD G PESTELL
-
依托单位:
Developmental Funds
-
批准号:8302938
-
项目类别:
-
资助金额:$35.16万
-
财政年份:2011
-
负责人:RICHARD G PESTELL
-
依托单位:
Radiation Research and Therapeutics
-
批准号:8302934
-
项目类别:
-
资助金额:$3.11万
-
财政年份:2011
-
负责人:RICHARD G PESTELL
-
依托单位:
Translational Research in Cancer
-
批准号:7934783
-
项目类别:
-
资助金额:$15.45万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis
-
批准号:8193135
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis
-
批准号:7653332
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
-
批准号:9446542
-
项目类别:
-
资助金额:$42.81万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis
-
批准号:7896701
-
项目类别:
-
资助金额:$32.06万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell fate determination factor and mammary tumorigenesis
-
批准号:8697542
-
项目类别:
-
资助金额:$34.88万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
DACH1/Eya Cell-fate determination factor and mammary tumoregenesis
-
批准号:8291884
-
项目类别:
-
资助金额:$31.1万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
Translational Research in Cancer
-
批准号:7934787
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
Translational Research in Cancer
-
批准号:7934802
-
项目类别:
-
资助金额:$95.69万
-
财政年份:2009
-
负责人:RICHARD G PESTELL
-
依托单位:
Cancer Center Administration
-
批准号:7712899
-
项目类别:
-
资助金额:$17.18万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Gastro Intestinal Cancer
-
批准号:7712909
-
项目类别:
-
资助金额:$2.08万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Developmental Funds
-
批准号:7712895
-
项目类别:
-
资助金额:$23.49万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Transgenic Knockout Mice
-
批准号:7712920
-
项目类别:
-
资助金额:$9.47万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Protocol Review and Monitoring System (PRMS)
-
批准号:7712938
-
项目类别:
-
资助金额:$2.82万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
Data Safety Monitoring Board (DSMB)
-
批准号:7712941
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2008
-
负责人:RICHARD G PESTELL
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: